SYNTHESIS AND IN- VIVO PHARMACOLOGICAL EVALUATION OF SOME NOVEL 4(3H)- QUINAZOLINONE DERIVATIVES AS POTENTIAL ANTI-MALARIAL AGENTS

Authors

  • Mohammed Hussen Bule Department of Pharmacy, College of Medicine and health Sciences, Ambo University, Ambo, Ethiopia.
  • Ariaya Haymete Department of Pharmaceutical Chemistry, Addis Ababa University, Addis Ababa, Ethiopia.
  • Belayneh kefale Department of Pharmacy, College of Medicine and health Sciences, Ambo University, Ambo, Ethiopia.

Keywords:

4(3H)-quinazolinones derivatives, in vivo, P. berghei, antimalarial.

Abstract

In this work six 3-aryl-2-(substitutedstyryl)-4(3H)-quinazolinones derivatives were synthesized by the reaction of 3-aryl-2-methyl-4(3H)-quinazolinone (intermediate products) with different substituted aromatic aldehydes. Three intermediate products were synthesized by reacting 2-methyl-3, 1-benzoxazin-4-one, which was initially prepared by cyclizing anthranilic acid using acetic anhydride, with three aromatic amines. Their structures were confirmed using IR, 1 HNMR, 13CNMR spectroscopic methods and elemental microanalyses. The synthesized compounds were evaluated for their in vivo antimalarial activity against P. berghei. Four of the synthesized compounds (IIIc, IVa, IVb and IVf) exhibited activity against the parasite. Among these compound IVa was found to be the most active compound. Results of acute toxicity study showed that oral administration of the synthesized compounds in single doses (100, 250 and 500mg/kg) had no adverse effects, indicating that the compounds have high safety margin and their LD50 is higher than 500 mg/kg. In general this study indicates that 4(3H)-quinazolinones derivatives are potential sources of lead compounds for antimalarial drugs.

Downloads

Download data is not yet available.

References

Oliveira, R.B., Souza-Fagundes, E.M., Soares, R. P., Andrade, A. A., Krettli, A.U. and Zani, C. L. (2008). Synthesis and antimalarial activity of semicarbazone and thiosemicarbazone derivatives. Eur. J. of Med. Chem., 43: 1983-1988.

The President’s Malaria Initiative (2009). Working with communities to save lives in Africa; Third annual report. http://www.pmi.gov/ (Accessed on 17.11.2009)

Kalra, S., Chawla, P., Gupta, N. and Valecha, K. (2006). Screening of antimalarial drugs: an overview. Indian J. Pharmacol, 38: 5-12.

Dawit, D., Eyassu, M., Asfaw, D., Dawit, A., Kelbessa, U., Wallelign, M., Daniel, M., Ashenafi, A. and Yared, M. (2006). In vivo anti-malarial activity of hydroalcoholic extracts from Asparagus africanus Lam. in mice infected with Plasmodium berghei. Ethiop. J. Heal. Dev, 20: 112-118.

Mbatchi, S.F., Mbatchi, B., Banzouzi, J.T., Bamsimba, T., Nsonde, G.F., Ntandou, J., Ouamba, M., Berry, A. and Benoit- Vical, F. (2006). In vitro antiplasmodial activity of 18 plants used in Congo Brazzaville traditional medicine. J. of Ethnopharmacol, 104: 168-174.

WHO (2008). World malaria report. Ethiopia, 69-71. http://www.who.int/malaria/ethiopia (Accessed on 12.12.2009).

Loiseau, P.M. and Xuong, N.D. (1996). Plasmodium berghei mouse model: antimalarial activity of new alkaloid salts and of thiosemicarbazone and acridine derivatives. Trop. Med. and Inter. Health., 1: 379– 384.

Ballon, W.R., Herrera, M.A., Caruca, D., Richei, T.L., Corradin, G. and Diggs, C. (2004). Uptake on the clinical development of candidate malaria vaccines. Am. J. Trop. Med. Hyg, 71: 239-47.

Schlu¨ter, K., Walter, R., Bergmann,B. and Kurz, T. (2006). Arylmethyl substituted derivatives of fosmidomycin: Synthesis and antimalarial activity. Eur. J. of Med. Chem., 41: 1385-1397.

Xue, C.X., Cui, S.Y., Liu, M.C., Hu, Z.D. and Fa, B.T. (2004). 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA. Eur. J. of Med. Chem., 39: 745–753.

Valla, A., Valla, B., Cartier, D., Guillou, R.L., Labia, R., Florent, L., Charneau, S., Schrevel, J. and Potier, P. (2006). New syntheses and potential antimalarial activities of new ‘retinoid-like chalcones’. Eur. J. of Med. Chem., 41: 142–146.

Salomé, E.H., Michèle, A., Jean-Luc, S., Marjorie, M., Henri, V., Geneviève, B.M. and Marc, P. (2009). Synthesis and antimalarial activity of new atovaquone derivatives, Eur. J. of Med. Chem., 48: 1-15.

Maarouf, A., El-Bendary, E. and Goda, F. (2004). Synthesis and evaluation of some novel quinazolinone derivatives as diuretic agents. Arch. Pharm. Med. Chem., 337: 527−532.

Rouvier, C.S., Pradines, B., Berthelot, M., Parzy, D. and Barbe, J. (2004). Arylsulfonyl acridinyl derivatives acting on Plasmodium falciparum. Eur. J. of Med. Chem., 39: 735–744.

Ahmed, M., Adnan A. K., El-Azab, A.S., Abdel-Hamide,

S.G. and Daba, M.H.Y. (2008). Synthesis, analgesic and anti-inflammatory evaluation of some new 3H- quinazolin-4-one derivatives. Arch. Pharm. Chem. Life Sci., 341, 377 – 385.

Bhattacharjee, A., Hartell, M., Nichols, D., Hicks, R., Stanton, B., Hamont, J. and Milhous, W. (2004). Structure-activity relationship study of antimalarial indolo [2,1-b]quinazoline-6,12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates. Eur. J. of Med. Chem., 39: 59–6.

Galli, U., Lazzarato, L., Bertinaria, M., Sorba, G., Gasco, A., Parapini, S., Taramelli, D. (2005). Synthesis and antimalarial activities of some furoxan sulfones and related furazans. Eur. J. of Med. Chem., 40: 1335– 1340.

Pandey, A., Singh, A., Singh, A. and Nizamuddin, B. (2009). Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]- triazine and [1,2,4,5]-tetrazine rings. Eur. J. of Med. Chem., 44: 1188-1197.

Grover, G. and Kini, S. (2006). Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents. Eur. J. of Med. Chem., 41: 256–262

Jata, V., Mishra, P., Kashaw, J. and Stables, J.P. (2008). CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. Eur. J. of Med. Chem., 43: 1945-1954.

Giri, R., Thaker, H., Giordano, T., Williams, J., Rogers, D., Sudersanam, V., Vasu, K. (2009). Design, synthesis and characterization of novel 2-(2,4-disubstituted- thiazole-5- yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-kB and AP-1 mediated transcription activation and as potential anti-inflammatory agents. Eur. J. of Med. Chem., 44: 2184–2189.

Abdulrahman, M., Al-Obaid, Abdel-Hamide, S.G., El- Kashef, H.A., Abdel-Aziz, A.A., El-Azab, A.S., Al- Khamees, H.A. and El-Subbagh, H.I. (2009). Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno- 4(3H)-quinazolinone analogs. Eur. J. of Med. Chem., 44: 2379–2391.

Farghaly, A. M., Soliman, R., Khalil, M. A. and Bekhit A.

A. (1994). Non-steroidal anti-inflammatory agents: synthesis of novel pyrazolyl-,1,2-oxazolyl-, and 1,3- diazinyl derivatives of 4(3H)-quinazolinones. Arch. Pharm. (Weinheim), 327: 27-35.

Farghaly A. M., Chaaban I., Khalil M. A., Bekhit A. A. (1990). Non-Steroidal anti-inflammatory agents. III: synthesis of novel pyrazole derivatives of 4(3H)- quinazolinones. Alex. J. Pharm. Sci., 4: 52-62.

Farghaly, A. M., Chaaban, I., Khalil, M. A. and Bekhit A.

A. (1990). Non-steroidal antiinflammatory agents, synthesis of novel 2-pyrazolyl-4(3H)-quinazolinones. Arch. Pharm. (Weinheim) 323: 833-40.

Peters, W. and Robinson, B.L. (1999). Parasitic infection models: Handbook of animal models of infection. Acad. Press., London: p757–773.

Bekhit, A.A. and Baraka, A.M. (2005). Novel milrinone analogs of pyridine-3-carbonitrile derivatives as promising cardiotonic agents. Eur. J. Med. Chem., 40: 1405–1413.

Kiseko, K., Hiroyuki, M., Syun-ichi, F., Ryuiichi, F., Tomotaka, K. and Seiji, M. (2000). Anti-malarial activity of leaf-extract of Hydrangea macrophyla, a common Japanese plant. Acta Med. Okayama, 54: 227-232.

United Nations Children’s Fund (2007). Malaria & children: Progress in intervention coverage. Geneva, 5- 13.http://www.unicef.org/progressforchildren/2007n6/ index_4183.html (Accessed on 03.12.2009).

Cravo, P., Culleton, R., Hunt, P., Walliker, D. and Margaret, J.M. (2001). Antimalarial drugs clear resistant parasites from partially immune hosts. Antimicrob. Agents and Chemother., 45: 2897–2901.

David, A., Philip, J., Simon, L., Reto, B. and Solomon, N. (2004). Antimalarial efficacy screening: in vitro and in vivo protocols. http://www.mmv.org /IMG/pdf/ screening pdf pp 1-9, (Accessed on 17.05.08).

OECD guideline for testing of chemicals (2001). Acute oral toxicity up and down procedure.¬ http:

//iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/OEC D_GL420.pdf. (Accessed on 23.08.07).

Published

2015-05-15

How to Cite

Bule, M. H. ., Haymete, A. ., & kefale, B. . (2015). SYNTHESIS AND IN- VIVO PHARMACOLOGICAL EVALUATION OF SOME NOVEL 4(3H)- QUINAZOLINONE DERIVATIVES AS POTENTIAL ANTI-MALARIAL AGENTS. International Journal of Research and Development in Pharmacy & Life Sciences, 4(3), 1506-1515. Retrieved from https://ijrdpl.com/index.php/ijrdpl/article/view/467